Literature DB >> 14979411

Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor.

Cetin Gül1, Turhan Kürüm, Muzaffer Demir, Gültaç Ozbay, Ozden Vural, Omer Iqbal, Jawed Fareed.   

Abstract

Essential thrombocythemia (ET) rarely causes obstruction of coronary arteries or acute myocardial infarction. Treatment of acute myocardial infarction in patients with ET may be a problem due to the important role of platelets in the pathogenesis of infarction. There is no reported case of acute myocardial infarction with essential thrombocythemia treated with a glycoprotein IIb/IIIa inhibitor. In this report, a 49-year-old woman with essential thrombocythemia, admitted with a diagnosis of acute inferolateral myocardial infarction, was treated with tirofiban, a glycoprotein IIb/IIIa receptor blocker.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14979411     DOI: 10.1177/107602960401000114

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  1 in total

1.  Essential thrombocythemia with non-ST-segment elevation myocardial infarction as the first manifestation: A case report.

Authors:  Zhi-Ming Wang; Wei-Hai Chen; Yan-Ming Wu; Lin-Quan Wang; Fu-Long Ye; Ren-Lin Yin
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.